Latest Breaking News On - Cabozantinib monotherapy - Page 1 : comparemela.com

Dr R. Katie Kelley explains the design and results of the phase 3 CELESTIAL study investigating single-agent cabozantinib for the treatment of advanced hepatocellular carcinoma.

R katie kelleyCabozantinib monotherapyHepatocellular carcinomaRecent updatesEvolving treatment paradigmsRecent data updates hepatocellular carcinomaHcc treatmentsHepatocellular carcinoma treatmentsEarly stage hepatocellular carcinomaHcc risk factorsPatients with hccHcc prognosisHepatocellular carcinoma prognosisHepatocellular carcinoma diagnosisClinical work upMolecular testing hcc